Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  HIV Infection

  Free Subscription


25.10.2021

1 AIDS
4 AIDS Res Hum Retroviruses
1 Am J Epidemiol
1 Am J Med
29 Clin Infect Dis
1 HIV Med
5 J Acquir Immune Defic Syndr
1 J Clin Immunol
1 J Clin Invest
2 J Infect Dis
4 J Virol
1 JAMA
1 PLoS Med
9 PLoS One
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. MILLS A, Richmond GJ, Newman C, Osiyemi O, et al
    Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression: pOLAR month 12 results.
    AIDS. 2021 Oct 13. pii: 00002030-900000000-96294.
    PubMed         Abstract available


    AIDS Res Hum Retroviruses

  2. KURLE S, Kandaswami S, Gadhe S, Patil A, et al
    HIV-1 Drug Resistance among treatment naive Transgenders from India.
    AIDS Res Hum Retroviruses. 2021 Oct 15. doi: 10.1089/AID.2021.0157.
    PubMed         Abstract available

  3. KUSAGAWA S, Tatsumi M, Sakamoto-Umeki Y, Takekawa N, et al
    Nucleotide sequence of HIV-1-positive specimen reference panel for evaluation of HIV in-vitro diagnostics in Japan.
    AIDS Res Hum Retroviruses. 2021 Oct 15. doi: 10.1089/AID.2021.0160.
    PubMed         Abstract available

  4. PEREIRA B, Mazzitelli M, Milinkovic A, Moyle G, et al
    Predictive value of HIV-related versus traditional risk factors for coronary atherosclerosis in people aging with HIV.
    AIDS Res Hum Retroviruses. 2021 Oct 15. doi: 10.1089/AID.2021.0064.
    PubMed         Abstract available

  5. KIERI O, Marrone G, Sonnerborg A, Nowak P, et al
    Incidence, treatment and outcome of HIV-associated hematologic malignancies in people living with HIV in Sweden.
    AIDS Res Hum Retroviruses. 2021 Oct 15. doi: 10.1089/AID.2021.0020.
    PubMed         Abstract available


    Am J Epidemiol

  6. WIGINTON JM, Murray SM, Augustinavicius J, Maksut JL, et al
    Characterizing Metrics of Sexual Behavior Stigmas among Cisgender Men Who Have Sex With Men in Nine Cities across the United States.
    Am J Epidemiol. 2021 Oct 19. pii: 6401651. doi: 10.1093.
    PubMed         Abstract available


    Am J Med

  7. PATEL CG, Tao G
    STI/HIV Testing, and Prevalence of Gonorrhea and Chlamydia Among Persons with their Specified-type Sex Partner.
    Am J Med. 2021 Oct 13. pii: S0002-9343(21)00643.
    PubMed         Abstract available


    Clin Infect Dis

  8. ROCKSTROH JK
    Hepatitis C (HCV) microelimination in HIV-coinfected men who have sex with men (MSM): A low hanging fruit?
    Clin Infect Dis. 2020 Aug 5. pii: 5881444. doi: 10.1093/cid/ciaa1113.
    PubMed        

  9. SRINIVASAN S, Chambers LC, Tapia KA, Hoffman NG, et al
    Urethral Microbiota in Men: Association of Haemophilus influenzae and Mycoplasma penetrans With Nongonococcal Urethritis.
    Clin Infect Dis. 2021;73:e1684-e1693.
    PubMed         Abstract available

  10. HACKETT S, Teasdale CA, Pals S, Muttiti A, et al
    Drug Resistance Mutations Among South African Children Living With HIV on WHO-recommended ART Regimens.
    Clin Infect Dis. 2021;73:e2217-e2225.
    PubMed         Abstract available

  11. NEILAN AM, Bulteel AJB, Hosek SG, Foote JHA, et al
    Cost-effectiveness of Frequent HIV Screening Among High-risk Young Men Who Have Sex With Men in the United States.
    Clin Infect Dis. 2021;73:e1927-e1935.
    PubMed         Abstract available

  12. SCHACKMAN BR
    The Value and Challenge of Frequent Human Immunodeficiency Virus (HIV) Testing Among Young Men Who Have Sex With Men in the United States.
    Clin Infect Dis. 2021;73:e1936-e1937.
    PubMed        

  13. ENGEL T, Raffenberg M, Schoepf IC, Kootstra NA, et al
    Telomere Length, Traditional Risk Factors, HIV-related Factors and Coronary Artery Disease Events in Swiss Persons Living with HIV.
    Clin Infect Dis. 2020 Jul 29. pii: 5877846. doi: 10.1093/cid/ciaa1034.
    PubMed         Abstract available

  14. CHANDRA C, Weiss KM, Kelley CF, Marcus JL, et al
    Gaps in Sexually Transmitted Infection Screening Among Men who Have Sex with Men in Pre-exposure Prophylaxis (PrEP) Care in the United States.
    Clin Infect Dis. 2021;73:e2261-e2269.
    PubMed         Abstract available

  15. SAMET JH, Tsui JI, Cheng DM, Liebschutz JM, et al
    Improving the Delivery of Chronic Opioid Therapy Among People Living With Human Immunodeficiency Virus: A Cluster Randomized Clinical Trial.
    Clin Infect Dis. 2021;73:e2052-e2058.
    PubMed         Abstract available

  16. DEUTSCHMANN E, Bucher HC, Jaeckel S, Gibbons S, et al
    Prevalence of Potential Drug-Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors.
    Clin Infect Dis. 2021;73:e2145-e2152.
    PubMed         Abstract available

  17. BARTLETT AW, Sudjaritruk T, Mohamed TJ, Anugulruengkit S, et al
    Identification, Management, and Outcomes of Combination Antiretroviral Treatment Failure in Adolescents With Perinatal Human Immunodeficiency Virus Infection in Asia.
    Clin Infect Dis. 2021;73:e1919-e1926.
    PubMed         Abstract available

  18. WU D, Zhou Y, Yang N, Huang S, et al
    Social media-based secondary distribution of HIV/syphilis self-testing among Chinese men who have sex with men.
    Clin Infect Dis. 2020 Jun 26. pii: 5863134. doi: 10.1093.
    PubMed         Abstract available

  19. ZHAO R, Tao Y, Zhang L
    Can Social Media-Based Self-testing Be a New Paradigm for Human Immunodeficiency Virus Testing in China?
    Clin Infect Dis. 2021;73:e2258-e2260.
    PubMed        

  20. JACOBS P, Feaster DJ, Pan Y, Gooden LK, et al
    Initiation of Antiretroviral Therapy in the Hospital Is Associated With Linkage to Human Immunodeficiency Virus (HIV) Care for Persons Living With HIV and Substance Use Disorder.
    Clin Infect Dis. 2021;73:e1982-e1990.
    PubMed         Abstract available

  21. PETTIT AC, Stout JE, Belknap R, Benson CA, et al
    Optimal testing choice and diagnostic strategies for latent tuberculosis infection among U.S.-born people living with HIV.
    Clin Infect Dis. 2020 Aug 6. pii: 5881730. doi: 10.1093/cid/ciaa1135.
    PubMed         Abstract available

  22. BRAUN DL, Hampel B, Ledergerber B, Grube C, et al
    A treatment as prevention trial to eliminate hepatitis C among men who have sex with men living with HIV in the Swiss HIV Cohort Study.
    Clin Infect Dis. 2020 Aug 6. pii: 5881825. doi: 10.1093/cid/ciaa1124.
    PubMed         Abstract available

  23. AJAYKUMAR A, Wong GC, Yindom LM, McHugh G, et al
    Shorter Granulocyte Telomeres Among Children and Adolescents With Perinatally Acquired Human Immunodeficiency Virus Infection and Chronic Lung Disease in Zimbabwe.
    Clin Infect Dis. 2021;73:e2043-e2051.
    PubMed         Abstract available

  24. DENTI P, Wasmann RE, van Rie A, Winckler J, et al
    Optimizing dosing and fixed-dose combinations of rifampicin, isoniazid, and pyrazinamide in pediatric patients with tuberculosis: a prospective population pharmacokinetic study.
    Clin Infect Dis. 2021 Oct 19. pii: 6403131. doi: 10.1093.
    PubMed         Abstract available

  25. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
    Severity, criticality, and fatality of the SARS-CoV-2 Beta variant.
    Clin Infect Dis. 2021 Oct 17. pii: 6398699. doi: 10.1093.
    PubMed         Abstract available

  26. MCCLUSKEY SM, Marconi VC
    High Baseline Viremia: An Achilles Heel for Integrase Inhibitor-Based Antiretroviral Therapy?
    Clin Infect Dis. 2021;73:e2142-e2144.
    PubMed        

  27. REBEIRO PF, Jenkins CA, Bian A, Lake JE, et al
    Risk of Incident Diabetes Mellitus, Weight Gain, and their Relationships with Integrase Inhibitor-based Initial Antiretroviral Therapy Among Persons with HIV in the US and Canada.
    Clin Infect Dis. 2020 Sep 16. pii: 5906580. doi: 10.1093/cid/ciaa1403.
    PubMed         Abstract available

  28. CARRERO A, Berenguer J, Hontanon V, Guardiola JM, et al
    Effects of HCV Eradication on Bone mineral density in HIV/HCV Coinfected Patients.
    Clin Infect Dis. 2020 Sep 15. pii: 5905898. doi: 10.1093/cid/ciaa1396.
    PubMed         Abstract available

  29. HELLMUTH J, Muccini C, Colby DJ, Kroon E, et al
    Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency Virus.
    Clin Infect Dis. 2021;73:e1885-e1892.
    PubMed         Abstract available

  30. MAURICE JB, Goldin R, Hall A, Price JC, et al
    Increased Body Mass Index and Type 2 Diabetes Are the Main Predictors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Liver Biopsies of Patients With Human Immunodeficiency Virus Monoinfection.
    Clin Infect Dis. 2021;73:e2184-e2193.
    PubMed         Abstract available

  31. LEONARD MA, Cindi Z, Bradford Y, Bourgi K, et al
    Efavirenz Pharmacogenetics and Weight Gain following Switch to Integrase Inhibitor-containing Regimens.
    Clin Infect Dis. 2020 Aug 23. pii: 5896036. doi: 10.1093/cid/ciaa1219.
    PubMed         Abstract available

  32. CROWELL TA, Danboise B, Parikh A, Esber A, et al
    Pre-Treatment and Acquired Antiretroviral Drug Resistance among Persons Living with HIV in Four African Countries.
    Clin Infect Dis. 2020 Aug 12. pii: 5891786. doi: 10.1093/cid/ciaa1161.
    PubMed         Abstract available

  33. LU H, Cole SR, Westreich D, Hudgens MG, et al
    Clinical effectiveness of integrase strand transfer inhibitor-based antiretroviral regimens among adults with human immunodeficiency virus: a collaboration of cohort studies in the United States and Canada.
    Clin Infect Dis. 2020 Aug 11. pii: 5891141. doi: 10.1093/cid/ciaa1037.
    PubMed         Abstract available

  34. CORMA-GOMEZ A, Macias J, Lacalle-Remigio JR, Tellez F, et al
    HIV infection is associated with lower risk of hepatocellular carcinoma after sustained virological response to direct-acting antivirals in hepatitis C infected-patients with advanced fibrosis.
    Clin Infect Dis. 2020 Aug 7. pii: 5885174. doi: 10.1093/cid/ciaa1111.
    PubMed         Abstract available

  35. GRANT RM, Pellegrini M, Defechereux PA, Anderson PL, et al
    Sex Hormone Therapy and Tenofovir Diphosphate Concentration in Dried Blood Spots: Primary Results of the iBrEATHe Study.
    Clin Infect Dis. 2020 Aug 8. pii: 5885191. doi: 10.1093/cid/ciaa1160.
    PubMed         Abstract available

  36. KRAKOWER DS
    Human Immunodeficiency Virus Preexposure Prophylaxis: Meeting the Needs of Transgender Populations.
    Clin Infect Dis. 2021;73:e2124-e2126.
    PubMed        


    HIV Med

  37. LAJAUNIE R, Cuzin L, Palich R, Makinson A, et al
    No increased risk of Kaposi sarcoma relapse in patients with controlled HIV-1 infection after switching protease inhibitor-based antiretroviral therapy.
    HIV Med. 2021 Oct 19. doi: 10.1111/hiv.13168.
    PubMed         Abstract available


    J Acquir Immune Defic Syndr

  38. SCHURMANN D, Rudd DJ, Schaeffer A, De Lepeleire I, et al
    Single oral doses of MK-8507, a novel non-nucleoside reverse transcriptase inhibitor, suppress HIV-1 RNA for a week.
    J Acquir Immune Defic Syndr. 2021 Oct 13. pii: 00126334-900000000-95781.
    PubMed         Abstract available

  39. MATTHEWS RP, Jackson Rudd D, Zhang S, Fillgrove KL, et al
    Safety and Pharmacokinetics of Once-Daily Multiple-Dose Administration of Islatravir in Adults Without HIV.
    J Acquir Immune Defic Syndr. 2021;88:314-321.
    PubMed         Abstract available

  40. GIACOMELLI A, Bonazzetti C, Conti F, Pezzati L, et al
    Brief Report: Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic.
    J Acquir Immune Defic Syndr. 2021;88:299-304.
    PubMed         Abstract available

  41. KATUREEBE C, Ashburn K, Machekano R, Gill MM, et al
    Developing and Validating an Effective Pediatric and Adolescent HIV Testing Eligibility Screening Tool for High-Volume Entry Points in Uganda.
    J Acquir Immune Defic Syndr. 2021;88:290-298.
    PubMed         Abstract available

  42. ZHU W, Huang YA, Kourtis AP, Hoover KW, et al
    Trends in the Number and Characteristics of HIV Pre-Exposure Prophylaxis Providers in the United States, 2014-2019.
    J Acquir Immune Defic Syndr. 2021;88:282-289.
    PubMed         Abstract available


    J Clin Immunol

  43. YAP JY, Moens L, Lin MW, Kane A, et al
    Intrinsic Defects in B Cell Development and Differentiation, T Cell Exhaustion and Altered Unconventional T Cell Generation Characterize Human Adenosine Deaminase Type 2 Deficiency.
    J Clin Immunol. 2021 Oct 17. pii: 10.1007/s10875-021-01141.
    PubMed         Abstract available


    J Clin Invest

  44. MENDEZ-LAGARES G, Chin N, Chang WLW, Lee J, et al
    Cytomegalovirus mediates expansion of IL-15-responsive innate-memory cells with SIV killing function.
    J Clin Invest. 2021;131.
    PubMed         Abstract available


    J Infect Dis

  45. STERN J, Solomon A, Dantanarayana A, Pascoe R, et al
    Cell-associated HIV RNA has a Circadian Cycle in Males Living with HIV on Antiretroviral Therapy.
    J Infect Dis. 2021 Oct 16. pii: 6398479. doi: 10.1093.
    PubMed         Abstract available

  46. ARRIAGA MB, Araujo-Pereira M, Barreto-Duarte B, Nogueira B, et al
    The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multi-center Prospective Cohort Study.
    J Infect Dis. 2021 Oct 15. pii: 6398049. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  47. SCHORCHT A, Cottrell CA, Pugach P, Ringe RP, et al
    The glycan hole area of HIV-1 envelope trimers contributes prominently to the induction of autologous neutralization.
    J Virol. 2021 Oct 20:JVI0155221. doi: 10.1128/JVI.01552.
    PubMed         Abstract available

  48. COLOMER-LLUCH M, Kilpelainen A, Pernas M, Pena R, et al
    Viral and Cellular factors leading to the Loss of CD4 Homeostasis in HIV-1 Viremic Nonprogressors.
    J Virol. 2021 Oct 20:JVI0149921. doi: 10.1128/JVI.01499.
    PubMed         Abstract available

  49. BELTRAN-PAVEZ C, Bontjer I, Gonzalez N, Pernas M, et al
    Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle (VLP) Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses.
    J Virol. 2021 Oct 20:JVI0134321. doi: 10.1128/JVI.01343.
    PubMed         Abstract available

  50. CACCURI F, Neves V, Gano L, Correia JDG, et al
    The HIV-1 matrix protein p17 does cross the Blood-Brain Barrier.
    J Virol. 2021 Oct 20:JVI0120021. doi: 10.1128/JVI.01200.
    PubMed         Abstract available


    JAMA

  51. KUEHN BM
    COVID-19 Rolls Back Progress Against HIV, TB, and Malaria.
    JAMA. 2021;326:1471.
    PubMed        


    PLoS Med

  52. STOVER J, Glaubius R, Teng Y, Kelly S, et al
    Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.
    PLoS Med. 2021;18:e1003831.
    PubMed         Abstract available


    PLoS One

  53. MWALABU G, Mbendera I, Petrucka P, Manjanja V, et al
    Female adolescents living with HIV telling their story through 'my story' book in Malawi: A visual methodology innovation.
    PLoS One. 2021;16:e0257126.
    PubMed         Abstract available

  54. LUKAS K, Markos E, Belayneh F, Habte A, et al
    The magnitude of hypertension and associated factors among clients on highly active antiretroviral treatment in Southern Ethiopia, 2020: A hospital-based cross-sectional study.
    PLoS One. 2021;16:e0258576.
    PubMed         Abstract available

  55. ORINDI BO, Ziraba A, Bruyneel L, Floyd S, et al
    Invariance of the WHO violence against women instrument among Kenyan adolescent girls and young women: Bayesian psychometric modeling.
    PLoS One. 2021;16:e0258651.
    PubMed         Abstract available

  56. LOVEDAY M, Hlangu S, Larkan LM, Cox H, et al
    "This is not my body": Therapeutic experiences and post-treatment health of people with rifampicin-resistant tuberculosis.
    PLoS One. 2021;16:e0251482.
    PubMed         Abstract available

  57. MWALE M, Muula AS
    Stakeholder acceptability of the risk reduction behavioural model [RRBM] as an alternative model for adolescent HIV risk reduction and sexual behavior change in Northern Malawi.
    PLoS One. 2021;16:e0258527.
    PubMed         Abstract available

  58. ANDRASIK MP, Broder GB, Wallace SE, Chaturvedi R, et al
    Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment.
    PLoS One. 2021;16:e0258858.
    PubMed         Abstract available

  59. ROHWER A, Hendricks L, Oliver S, Garner P, et al
    Testing for saturation in qualitative evidence syntheses: An update of HIV adherence in Africa.
    PLoS One. 2021;16:e0258352.
    PubMed         Abstract available

  60. IZUDI J, Okoboi S, Lwevola P, Kadengye D, et al
    Effect of disclosure of HIV status on patient representation and adherence to clinic visits in eastern Uganda: A propensity-score matched analysis.
    PLoS One. 2021;16:e0258745.
    PubMed         Abstract available

  61. O'BRYAN G, Feldacker C, Ensminger A, Nghatanga M, et al
    Adverse event profile and associated factors following surgical voluntary medical male circumcision in two regions of Namibia, 2015-2018.
    PLoS One. 2021;16:e0258611.
    PubMed         Abstract available


    Virology

  62. MACDONALD-OTTEVANGER MS, Boyd A, Prins M, van der Helm JJ, et al
    Differences in prevalence of hepatitis B virus infection and genotypes between ethnic populations in Suriname, South America.
    Virology. 2021;564:53-61.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: